Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Zeria Pharmaceutical Co stock

4559.T
JP3428850006

Price

2,292.00
Today +/-
+0.34
Today %
+2.38 %

Zeria Pharmaceutical Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Zeria Pharmaceutical Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Zeria Pharmaceutical Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Zeria Pharmaceutical Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Zeria Pharmaceutical Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Zeria Pharmaceutical Co Stock Price History

DateZeria Pharmaceutical Co Price
11/28/20242,292.00 undefined
11/27/20242,238.00 undefined
11/26/20242,257.00 undefined
11/25/20242,241.00 undefined
11/22/20242,244.00 undefined
11/21/20242,221.00 undefined
11/20/20242,216.00 undefined
11/19/20242,216.00 undefined
11/18/20242,216.00 undefined
11/15/20242,229.00 undefined
11/14/20242,231.00 undefined
11/13/20242,260.00 undefined
11/12/20242,240.00 undefined
11/11/20242,221.00 undefined
11/8/20242,217.00 undefined
11/7/20242,255.00 undefined
11/6/20242,372.00 undefined
11/5/20242,375.00 undefined
11/1/20242,304.00 undefined
10/31/20242,330.00 undefined

Zeria Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Zeria Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Zeria Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Zeria Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Zeria Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Zeria Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Zeria Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Zeria Pharmaceutical Co’s growth potential.

Zeria Pharmaceutical Co Revenue, EBIT and net profit per share

DateZeria Pharmaceutical Co RevenueZeria Pharmaceutical Co EBITZeria Pharmaceutical Co Net Income
2027e98.78 B undefined0 undefined10.81 B undefined
2026e90.9 B undefined0 undefined9.29 B undefined
2025e84.34 B undefined0 undefined8.08 B undefined
202475.73 B undefined9.14 B undefined7.73 B undefined
202368.38 B undefined9.01 B undefined6.2 B undefined
202259.53 B undefined6.37 B undefined3.96 B undefined
202152.76 B undefined3.48 B undefined3.14 B undefined
202060.43 B undefined4.09 B undefined2.93 B undefined
201961.83 B undefined3.74 B undefined3.45 B undefined
201864.57 B undefined4.83 B undefined4.16 B undefined
201764.85 B undefined4.54 B undefined3.54 B undefined
201662.48 B undefined4.57 B undefined3.51 B undefined
201561.01 B undefined2.68 B undefined2.56 B undefined
201462 B undefined6.79 B undefined5.28 B undefined
201353.32 B undefined4.61 B undefined3.98 B undefined
201253.17 B undefined4.57 B undefined2.86 B undefined
201149.48 B undefined3.31 B undefined1.84 B undefined
201050.75 B undefined1.58 B undefined1 B undefined
200947.67 B undefined1.33 B undefined1.2 B undefined
200849.72 B undefined2.56 B undefined1.64 B undefined
200752.76 B undefined3.44 B undefined2.07 B undefined
200655.55 B undefined1.95 B undefined1.25 B undefined
200556.21 B undefined2.42 B undefined1.39 B undefined

Zeria Pharmaceutical Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
54.8756.1855.7753.8455.0654.3856.2155.5552.7649.7247.6750.7549.4853.1753.326261.0162.4864.8564.5761.8360.4352.7659.5368.3875.7384.3490.998.78
-2.39-0.74-3.462.26-1.243.37-1.18-5.02-5.75-4.136.45-2.497.450.2816.28-1.592.403.80-0.43-4.24-2.27-12.6912.8414.8710.7411.377.788.67
54.4254.7854.4752.6252.3650.4252.2351.7554.2554.6853.3154.0862.7365.1267.0070.4169.6471.3071.9871.5971.2972.4670.0670.8072.3773.2965.8161.0656.19
29.8630.7830.3728.3328.8327.4229.3628.7528.6227.1925.4127.4531.0434.6235.7243.6542.4944.5446.6846.2344.0843.7836.9642.1549.4955.5000
2.723.111.371.452.041.551.391.252.071.641.211.842.863.985.282.563.513.544.163.452.933.143.966.27.738.089.2910.81
-14.59-56.096.0840.79-23.82-10.88-9.8265.57-20.74-26.60-16.7183.9355.2439.1832.52-51.5437.390.8817.30-16.91-15.327.4526.0356.4024.794.5114.9916.30
-----------------------------
-----------------------------
5353535352504847464646464545454653.1253.1253.1251.5149.6646.7146.0745.1444.1744.08000
-----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Zeria Pharmaceutical Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Zeria Pharmaceutical Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                   
4.162.562.992.953.712.312.922.152.152.482.813.574.955.717.3722.218.0112.349.3510.178.059.019.811.716.2220.32
25.0627.6330.1723.518.9716.9916.0815.1713.871212.3213.1212.2812.5913.6115.4716.2214.7216.5915.5914.9113.2413.1915.9217.1420.82
0000000000000000000000306.86231.44281.19259.63
5.594.535.725.754.783.73.943.824.835.215.756.215.236.076.547.738.198.018.619.3810.029.5611.111.9512.7614.49
0.951.612.292.082.042.452.332.873.423.323.943.262.72.862.714.493.264.614.223.375.743.212.921.861.81.92
35.7536.3341.1734.2929.525.4525.2624.0124.2823.0124.8326.1625.1727.2230.2449.945.6839.738.7638.5138.7235.0237.3141.6648.257.81
14.8714.2916.0115.7715.8115.6115.4117.4119.9819.6219.8920.721.5421.0521.2221.9522.0223.2724.1523.3422.9123.1323.6323.1424.5926.52
2.313.682.311.581.484.146.638.157.456.435.667.168.59.7710.5710.559.7312.479.216.945.545.975.927.016.859.15
00000000000000000000000000
0.550.450.180.20.170.211.271.151.381.661.671.421.241.261.111.010.817.286.726.97.017.317.697.848.479.38
0000000000010.2112.6911.8511.5112.2411.5328.5127.1625.4422.7922.5434.3833.3733.4633.76
1.191.812.983.193.352.96.65.825.435.716.075.324.654.053.63.846.497.958.3514.2813.4610.1912.9311.2713.4613.92
18.9320.2321.4820.7420.8122.8629.932.5334.2433.4233.2844.8148.6147.9848.0149.5950.5979.4875.5976.971.7169.1484.5582.6286.8392.72
54.6856.5662.6555.0250.3148.355.1656.5458.5256.4258.1170.9773.7875.278.2599.4996.27119.18114.36115.4110.43104.16121.86124.28135.03150.53
                                                   
6.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.596.59
5.45.45.45.45.45.45.45.425.425.425.425.425.425.425.4212.7212.7212.0611.6911.6911.6911.6911.6911.6911.6911.69
13.9316.8217.3217.8619.0920.9921.8623.5124.1723.9422.9823.2323.6227.6530.634.7236.3937.8139.6542.143.8244.8346.3548.8653.4659.25
000000000000.05-0-0.520.743.45.46.45.1910.017.673.76.215.5412.2918.35
0000000000000-1.470.711.311.4700.230.75-0.02-0.460.14-0.19-0.312
25.9228.8129.3129.8531.0832.9833.8535.5236.1835.9534.9935.2935.6237.6644.0558.7462.5762.8663.3671.1369.7566.3670.9872.4983.7197.89
97.638.938.147.956.527.26.495.915.144.975.133.373.343.313.722.382.042.272.071.761.591.692.0523.27
1.211.411.41.031.160.980.990.870.940.920.830.931.081.381.291.911.111.241.221.211.181.221.271.531.551.58
4.714.595.914.465.654.094.244.254.034.412.963.934.45.074.987.736.845.928.627.957.918.326.476.548.4511.03
0000000000000012.490031.4231.2921.8825.3726.8940.2228.4329.4729.94
9.7310.711.796.971.553.4310.328.258.047.5113.0825.9121.1415.042.7612.5911.577.621.773.052.623.054.155.645.698.69
24.6524.3328.0320.616.3115.0222.7419.8618.9217.9821.8435.8929.9924.8324.8325.9521.9148.2545.1836.1638.8441.0753.844.1947.1654.52
1.40.61.721.511.351.222.835.598.748.457.956.1714.5819.1215.6713.8710.644.652.888.687.86.466.7419.2215.558.95
00000000000.070.140.210.290.360.520.521.31.783.823.542.553.343.915.196.45
2.712.823.593.192.942.741.881.741.271.040.550.770.580.470.480.420.640.911.011.050.911.391.831.871.460.79
4.113.425.314.74.293.964.717.3310.019.488.567.0815.3719.8816.5114.8111.796.875.6713.5412.2510.4111.912522.216.19
28.7627.7533.3425.2920.618.9827.4527.1928.9227.4630.442.9845.3644.7141.3440.7633.755.1150.8549.751.0951.4865.7169.1969.3570.7
54.6856.5662.6455.1451.6851.9561.2962.765.163.4165.3978.2680.9882.3785.3899.596.27117.97114.21120.84120.84117.83136.69141.68153.07168.59
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Zeria Pharmaceutical Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Zeria Pharmaceutical Co's financial health and stability.

Assets

Zeria Pharmaceutical Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Zeria Pharmaceutical Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Zeria Pharmaceutical Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Zeria Pharmaceutical Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
6.052.9134.212.972.572.233.62.7821.572.764.686.027.313.825.264.925.585.223.923.925.727.27
1.121.020.750.680.681.081.451.612.082.232.442.873.162.842.622.713.123.793.843.733.944.445.46.15
000000000000000000000000
-6.62-4.952.924.09-1.650.47-2.33-1.63-0.53-4.021.64-0.05-1.99-3.55-3.36-3.43-2.04-1.010.13-1.51-0.66-1.4-2.48-0.43
0.673.130.580.71-0.66-0.66-0.08-0.82-0.570.210.210.260.17-1.430-2.1-0.64-0.46-0.72-1.950.1-0.070.440.17
1741931299666114126189247260268295291288245207259289187200232223304300
3.753.052.281.12.61.071.210.521.330.990.521.061.1222.252.021.560.450.441.0810.530.870.56
1.222.117.249.691.343.471.272.753.760.425.865.856.033.886.5715.697.248.825.57.36.899.0813.16
-244-909-474-541-556-1,299-2,040-4,711-1,385-1,123-1,922-1,992-1,394-1,617-3,192-1,877-28,947-3,722-2,042-1,517-1,273-16,132-1,420-2,657
-2.14-1.99-1.58-0.84-0.82-8.11-2.03-4.88-2.1-3.36-15.48-7.29-2.570.57-2.010.48-32.71-0.71.56-2.86-0.41-17.46-2.89-2.57
-1.9-1.08-1.1-0.3-0.26-6.810.01-0.16-0.71-2.24-13.56-5.3-1.172.191.182.35-3.763.023.61-1.340.87-1.33-1.470.08
000000000000000000000000
0.170.65-5.04-5.571.748.50.72.94-0.824.2211.053.55-1.56-2.3-4.46-4.2524-6.7-2.32.15-0.9913.91-0.7-5.15
-0.140-0.12-1.27-2.28-2.49-0.02-0.42-0.4-0.29-0.01-0.01-0.01-0.0114.61-000-5.61-4.98-3.29-1.15-2.6-0.67
-0.69-0.13-5.92-7.6-1.275.3-02.14-1.343.2610.372.84-2.43-3.349-5.8422.42-8.98-9.63-4.53-5.8811.19-4.84-7.42
000000029855200000000-592-7-5-2-3-3-3
-723-772-769-764-737-705-679-676-665-668-658-700-863-1,029-1,152-1,586-1,587-1,694-1,710-1,702-1,597-1,567-1,538-1,589
-1.61-0.01-0.251.25-0.750.61-0.780.010.330.320.771.380.761.6514.84-4.19-5.67-3.090.92-2.110.960.791.914.51
9761,2006,7699,149.7783.42,168.6-775-1,962.32,374.2-699.43,935.33,855.14,634.12,261.23,380.7-880.51-23,253.13,516.436,779.063,982.96,021.88-9,238.377,659.8610,499.68
000000000000000000000000

Zeria Pharmaceutical Co stock margins

The Zeria Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zeria Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zeria Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Zeria Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Zeria Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Zeria Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Zeria Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Zeria Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Zeria Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Zeria Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Zeria Pharmaceutical Co Margin History

Zeria Pharmaceutical Co Gross marginZeria Pharmaceutical Co Profit marginZeria Pharmaceutical Co EBIT marginZeria Pharmaceutical Co Profit margin
2027e73.29 %0 %10.94 %
2026e73.29 %0 %10.22 %
2025e73.29 %0 %9.58 %
202473.29 %12.08 %10.21 %
202372.37 %13.18 %9.06 %
202270.8 %10.69 %6.65 %
202170.06 %6.59 %5.96 %
202072.46 %6.78 %4.84 %
201971.29 %6.04 %5.59 %
201871.59 %7.48 %6.44 %
201771.98 %7 %5.47 %
201671.3 %7.31 %5.62 %
201569.64 %4.39 %4.19 %
201470.41 %10.95 %8.51 %
201367 %8.65 %7.47 %
201265.12 %8.59 %5.38 %
201162.73 %6.69 %3.72 %
201054.08 %3.12 %1.97 %
200953.31 %2.78 %2.52 %
200854.68 %5.15 %3.3 %
200754.25 %6.52 %3.92 %
200651.75 %3.5 %2.25 %
200552.23 %4.31 %2.46 %

Zeria Pharmaceutical Co Stock Sales Revenue, EBIT, Earnings per Share

The Zeria Pharmaceutical Co earnings per share therefore indicates how much revenue Zeria Pharmaceutical Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zeria Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zeria Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zeria Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zeria Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zeria Pharmaceutical Co Revenue, EBIT and net profit per share

DateZeria Pharmaceutical Co Sales per ShareZeria Pharmaceutical Co EBIT per shareZeria Pharmaceutical Co Earnings per Share
2027e2,240.9 undefined0 undefined245.13 undefined
2026e2,062.18 undefined0 undefined210.79 undefined
2025e1,913.25 undefined0 undefined183.32 undefined
20241,717.9 undefined207.46 undefined175.39 undefined
20231,548.07 undefined204.08 undefined140.26 undefined
20221,318.88 undefined141.03 undefined87.76 undefined
20211,145.11 undefined75.44 undefined68.22 undefined
20201,293.55 undefined87.66 undefined62.62 undefined
20191,245.22 undefined75.26 undefined69.56 undefined
20181,253.58 undefined93.78 undefined80.72 undefined
20171,220.93 undefined85.5 undefined66.73 undefined
20161,176.21 undefined85.96 undefined66.15 undefined
20151,148.66 undefined50.43 undefined48.15 undefined
20141,347.76 undefined147.61 undefined114.72 undefined
20131,184.84 undefined102.47 undefined88.49 undefined
20121,181.56 undefined101.53 undefined63.58 undefined
20111,099.6 undefined73.58 undefined40.96 undefined
20101,103.17 undefined34.43 undefined21.78 undefined
20091,036.3 undefined28.8 undefined26.15 undefined
20081,080.91 undefined55.67 undefined35.63 undefined
20071,146.89 undefined74.74 undefined44.96 undefined
20061,181.81 undefined41.38 undefined26.57 undefined
20051,171.02 undefined50.48 undefined28.85 undefined

Zeria Pharmaceutical Co business model

Zeria Pharmaceutical Co is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Zeria Pharmaceutical Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Zeria Pharmaceutical Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Zeria Pharmaceutical Co shares outstanding

The number of shares was Zeria Pharmaceutical Co in 2023 — This indicates how many shares 44.173 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zeria Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zeria Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zeria Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zeria Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zeria Pharmaceutical Co stock splits

In Zeria Pharmaceutical Co's history, there have been no stock splits.

Zeria Pharmaceutical Co dividend history and estimates

In 2023, Zeria Pharmaceutical Co paid a dividend amounting to 44 JPY. Dividend means that Zeria Pharmaceutical Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Zeria Pharmaceutical Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Zeria Pharmaceutical Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Zeria Pharmaceutical Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Zeria Pharmaceutical Co Dividend History

DateZeria Pharmaceutical Co Dividend
2027e46.75 undefined
2026e46.73 undefined
2025e46.78 undefined
202445 undefined
202344 undefined
202236 undefined
202134 undefined
202034 undefined
201934 undefined
201834 undefined
201733 undefined
201632 undefined
201530 undefined
201430 undefined
201325.45 undefined
201222.73 undefined
201119.09 undefined
201015.45 undefined
200914.55 undefined
200814.55 undefined
200714.55 undefined
200614.55 undefined
200514.55 undefined

Zeria Pharmaceutical Co dividend payout ratio

In 2023, Zeria Pharmaceutical Co had a payout ratio of 48.38%. The payout ratio indicates the percentage of the company's profits that Zeria Pharmaceutical Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Zeria Pharmaceutical Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Zeria Pharmaceutical Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Zeria Pharmaceutical Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Zeria Pharmaceutical Co Payout Ratio History

DateZeria Pharmaceutical Co Payout ratio
2027e46.13 %
2026e46.69 %
2025e45.27 %
202446.41 %
202348.38 %
202241.02 %
202149.84 %
202054.29 %
201948.88 %
201842.12 %
201749.45 %
201648.38 %
201562.3 %
201426.15 %
201328.77 %
201235.75 %
201146.62 %
201070.96 %
200955.62 %
200840.82 %
200732.36 %
200654.72 %
200550.42 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Zeria Pharmaceutical Co.

Zeria Pharmaceutical Co shareholders

%
Name
Stocks
Change
Date
12.09256 % Ibe Co.5,330,347589,3475/13/2024
4.78011 % MUFG Bank, Ltd.2,107,050507/22/2024
4.17427 % Morinaga Milk Industry Co Ltd1,840,00003/31/2024
3.61385 % Ibe (Sachiaki)1,592,9679675/13/2024
3.18999 % Sumitomo Mitsui Banking Corp1,406,1311314/1/2024
3.18969 % Mizuho Bank, Ltd.1,406,00003/31/2024
2.25920 % The Vanguard Group, Inc.995,84734,7009/30/2024
2.16993 % Mitsubishi UFJ Trust and Banking Corporation956,497956,4977/22/2024
2.04380 % Sumitomo Mitsui Card Company Ltd.900,900900,9004/1/2024
1.96690 % Kissei Pharmaceutical Co Ltd867,00003/31/2024
1
2
3
4
5
...
10

Most common questions regarding Zeria Pharmaceutical Co

What is the P/E ratio of Zeria Pharmaceutical Co 2024?

The Zeria Pharmaceutical Co P/E ratio is 13.07.

What is the P/S ratio of Zeria Pharmaceutical Co 2024?

The Zeria Pharmaceutical Co P/S ratio is 1.33.

What is the Quality Investing of Zeria Pharmaceutical Co?

The Quality Investing for Zeria Pharmaceutical Co is 5/10.

What is the revenue of Zeria Pharmaceutical Co 2024?

The Zeria Pharmaceutical Co revenue is 75.73 B JPY.

How high is the profit of Zeria Pharmaceutical Co 2024?

The Zeria Pharmaceutical Co profit is 7.73 B JPY.

What is the business model of Zeria Pharmaceutical Co

No history available for Zeria Pharmaceutical Co.

What is the Zeria Pharmaceutical Co dividend?

Zeria Pharmaceutical Co pays a dividend of 36 JPY distributed over payouts per year.

How often does Zeria Pharmaceutical Co pay dividends?

The dividend cannot currently be calculated for Zeria Pharmaceutical Co or the company does not pay out a dividend.

What is the Zeria Pharmaceutical Co ISIN?

The ISIN of Zeria Pharmaceutical Co is JP3428850006.

What is the Zeria Pharmaceutical Co ticker?

The ticker of Zeria Pharmaceutical Co is 4559.T.

How much dividend does Zeria Pharmaceutical Co pay?

Over the past 12 months, Zeria Pharmaceutical Co paid a dividend of 45 JPY . This corresponds to a dividend yield of about 1.96 %. For the coming 12 months, Zeria Pharmaceutical Co is expected to pay a dividend of 46.78 JPY.

What is the dividend yield of Zeria Pharmaceutical Co?

The current dividend yield of Zeria Pharmaceutical Co is 1.96 %.

When does Zeria Pharmaceutical Co pay dividends?

Zeria Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Zeria Pharmaceutical Co?

Zeria Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Zeria Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 46.78 JPY are expected. This corresponds to a dividend yield of 2.04 %.

In which sector is Zeria Pharmaceutical Co located?

Zeria Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zeria Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zeria Pharmaceutical Co from 12/1/2024 amounting to 23 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Zeria Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Zeria Pharmaceutical Co in the year 2023?

In the year 2023, Zeria Pharmaceutical Co distributed 44 JPY as dividends.

In which currency does Zeria Pharmaceutical Co pay out the dividend?

The dividends of Zeria Pharmaceutical Co are distributed in JPY.

All fundamentals about Zeria Pharmaceutical Co

Our stock analysis for Zeria Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zeria Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.